Related Experiment Videos
Integrating pharmacogenomics into pharmacy practice via medication therapy management
Journal of the American Pharmacists Association : Japha
|October 18, 2011
Summary
Pharmacogenomics integration into medication therapy management (MTM) can enhance patient care. Realizing this potential requires defining processes, business models, and health information technology (HIT) solutions to support pharmacists.
Area of Science:
- Pharmacogenomics and its role in personalized medicine.
- Advancements in gene-based healthcare delivery.
Background:
- The U.S. Department of Health & Human Services (HHS) launched the Personalized Health Care Initiative in 2006 to establish a foundation for gene-based care.
- Drug manufacturers and the Food and Drug Administration (FDA) are increasingly incorporating pharmacogenomic data into drug development and approval processes.
Purpose of the Study:
- To explore the application and integration of pharmacogenomics within pharmacy clinical practice, specifically through Medication Therapy Management (MTM).
- To identify strategies for improving patient care by leveraging pharmacogenomic information.
Main Methods:
- Review of the HHS Personalized Health Care Initiative and FDA pharmacogenomics activities.
- Analysis of findings from the American Pharmacists Association (APhA) stakeholder workshop on integrating pharmacogenomics into prescribing and dispensing.
- Consideration of diverse stakeholder perspectives including pharmacy, medicine, HIT, and academia.
Main Results:
- Emerging roles for pharmacists in utilizing pharmacogenomic information to enhance patient care are developing.
- Connectivity within electronic health record (EHR) infrastructure is crucial for pharmacists to access and exchange critical health information.
- Overcoming existing barriers and system limitations is essential for pharmacogenomics to reach its full potential in clinical practice.
Conclusions:
- The pharmacy profession must establish clear processes for applying pharmacogenomic data within MTM.
- Development of sustainable business models is necessary for pharmacogenomics-informed pharmacy practices.
- Encouraging the development of health information technology (HIT) solutions is vital to support pharmacists in this evolving field.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.